Production (Stage)
Scinai Immunotherapeutics Ltd.
SCNI
$2.72
$0.031.12%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.67% | -59.02% | -65.40% | -- | -29.33% |
| Total Receivables | -40.71% | -- | 232.73% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.27% | 134.78% | 57.78% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -6.43% | 9.52% | 0.00% | -- | -- |
| Total Current Assets | -56.10% | -52.93% | -62.09% | -- | -28.62% |
|
|
|||||
| Total Current Assets | -56.10% | -52.93% | -62.09% | -- | -28.62% |
| Net Property, Plant & Equipment | -8.05% | -7.69% | -5.29% | -- | -13.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -23.03% | -25.36% | -35.45% | -- | -22.00% |
|
|
|||||
| Total Accounts Payable | -29.72% | 1.08% | -25.28% | -- | 2.40% |
| Total Accrued Expenses | -8.01% | -- | -31.53% | -- | -24.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.07% | -7.61% | 3.66% | -- | 67.53% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.46% | -11.44% | -23.87% | -- | -2.95% |
|
|
|||||
| Total Current Liabilities | 1.46% | -11.44% | -23.87% | -- | -2.95% |
| Long-Term Debt | -98.66% | -14.91% | -3.56% | -- | 7.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 75.91% | -30.96% | -26.07% | -- | -42.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.88% | -99.67% | -98.20% | -- | 8,869.70% |
| Total Liabilities | -84.25% | -18.05% | -23.54% | -- | 13.27% |
|
|
|||||
| Common Stock & APIC | 3.45% | 3.00% | 2.95% | -- | -4.58% |
| Retained Earnings | 3.92% | -3.01% | -5.61% | -- | -2.04% |
| Treasury Stock & Other | 0.00% | 0.00% | 13.30% | -- | -- |
| Total Common Equity | 195.21% | -2.42% | -159.60% | -- | -195.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 195.21% | -2.42% | -159.60% | -- | -195.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 318.36% | -2.42% | -159.60% | -- | -195.17% |
|
|
|||||